96718 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tripeptides containing heteroatoms different from O, S, or N
PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#2CLASS OF PLATINUM COMPOUNDS FOR TREATING CANCER, AND METHOD FOR PREPARATION THEREOF
#3OLIGOPEPTIDE LINKER INTERMEDIATE AND PREPARATION METHOD THEREOF
#4Peptide macrocycles against
#5Peptidomimetics for the treatment of coronavirus and picorna virus infections
#6COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#7Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
#8OLIGOPEPTIDE LINKER INTERMEDIATE AND PREPARATION METHOD THEREOF
#9COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#10Peptidomimetics for the treatment of coronavirus and picornavirus infections
#11Compounds for proteasome enzyme inhibition
#12MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
#13COMPOUNDS FOR PROTEASOME
#14Inhibitors of hepatitis C virus
#15Peptide macrocycles against
#16Group of peptides for treating female sexual dysfunction
#17MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
#18Compounds
#1918F labeled amino acids, derivatives thereof and method of making same
#20COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#21Neuropeptide S receptor (NPSR) agonists
#22Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
#23Inhibitors of hepatitis C virus
#24Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
#25Difluoroketamide derivatives as HtrA1 inhibitors
#26Peptide macrocycles against Acinetobacter baumannii
#27Gelatinase inhibitors and use thereof
#28MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
#29Indoline compounds as granzyme B inhibitors
#30Peptide macrocycles against acinetobacter baumannii
#31Agonists of neurotrophin receptors and their use as medicaments
#32Inhibitors of hepatitis C virus
#33FLUORINATED EPOXYKETONE-BASED COMPOUNDS AND USES THEREOF AS PROTEASOME INHIBITORS
#34ALKOXYSILANE DERIVATIVES OF N-ACYL AMINO ACIDS, N-ACYL DIPEPTIDES, AND N-ACYL TRIPEPTIDES, AND PARTICLES AND STABLE OIL-IN-WATER FORMULATIONS USING THE SAME
#35Intermediates for macrocyclic compounds
#36Crystal forms
#37Indoline compounds as granzyme B inhibitors
#38Hepatitis C virus inhibitors
#39SMALL MOLECULE MODULATORS OF PCSK9 AND METHODS OF USE THEREOF
#40Antifouling materials
#41Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors
#42HCV protease inhibitors and uses thereof
#43Peptoids useful for the mineralization of apatite
#44Macrocyclic modulators of the ghrelin receptor
#45Hepatitis C virus inhibitors
#46Hepatitis C virus inhibitors
#47Agonists of neurotrophin receptors and their use as medicaments
#48HCV protease inhibitors and uses thereof
#49Components for producing amphoteric liposomes
#50Macrocyclic proline derived HCV serine protease inhibitors
#51Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
#52Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
#53Hepatitis C virus inhibitors
#54Inhibitors of hepatitis C virus
#55HCV protease inhibitors and uses thereof
#56Smart pro-drugs of serine protease inhibitors
#57Macrocyclic modulators of the Ghrelin receptor
#58Derivatives of glyco-CF-serine and glyco-CF-threonine
#59Methods and systems for preparing irreversible inhibitors of protein tyrosine phosphatases
#60Quinoxaline-containing compounds as hepatitis C virus inhibitors
#61Hepatitis C virus inhibitors
#62Compounds for immunoproteasome inhibition
#63Hepatitis C virus inhibitors
#64Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use
#65Compounds For Enzyme Inhibition
#66Hepatitis C Inhibitor Compounds
#67NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#68Processes for preparing protease inhibitors of hepatitis C virus
#69PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS
#70PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS
#71PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS
#72Substituted propane phosphinic acid derivatives
#73Inhibitors of IAP
#74HCV protease inhibitors and uses thereof
#75Macrocyclic hepatitis C serine protease inhibitors
#76Biologically active peptides and their new uses
#77PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS
#78Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors
#79Compounds for enzyme inhibition
#80Compounds for enzyme inhibition
#81Compounds For Enzyme Inhibition
#82Compounds For Enzyme Inhibition
#83Components for producing amphoteric liposomes
#84Compounds for enzyme inhibition
#85Compounds for enzyme inhibition
#86Compounds for enzyme inhibition
#87Compounds for enzyme inhibition
#88Alkoxysilane derivatives of N-acyl amino acids, N-acyl dipeptides, and N-acyl tripeptides, and particles and stable oil-in-water formulations using the same
#89Macrocyclic proline derived HCV serine protease inhibitors
#90Agonists of neurotrophin receptors and their use as medicaments
#91Hepatitis C Inhibitor Compounds
#92Diamine Derivatives
#93Peptidic compounds
#94Hepatitis C virus inhibitors
#95Boronic ester and acid compounds, synthesis and uses
#96Methods of treating cachexia with macrocyclic modulators of the ghrelin receptor
#97ORGANIC COMPOUNDS
#98METAL-BINDING COMPOUNDS AND USES THEREFOR
#99Compounds and compositions as channel activating protease inhibitors
#100Processes for intermediates for macrocyclic compounds
#101Spatially-defined macrocyclic compounds useful for drug discovery
#102Metal-binding compounds and uses therefor
#103Metal-binding compounds and uses therefor
#104IAP BIR DOMAIN BINDING COMPOUNDS
#105Hepatitis C inhibitor compounds
#106Inhibitors of serine proteases
#107NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS
#108Diamine Derivatives
#109HCV NS3 protease inhibitors
#110Stabilized vitamin C derivatives having a peptide molecule, preparation method thereof, and composition containing the same
#111MACROCYCLIC HEPATITIS C PROTEASE INHIBITORS
#112BOROPEPTIDE INHIBITORS OF ENTEROPEPTIDASE AND THEIR USES IN TREATMENT OF OBESITY, OVERWEIGHT AND/OR DISEASES ASSOCIATED WITH AN ABNORMAL FAT METABOLISM
#113Inhibitors of IAP
#114Metal-binding compounds and uses therefor
#115Organic Compounds and their uses
#116Imaging probes
#117Smart Pro-Drugs of Serine Protease Inhibitors
#118HCV NS3 PROTEASE INHIBITORS
#1192-Azetidinone Derivatives For The Treatment Of Hyperlipidaemic Diseases
#120Metal-binding compounds and uses therefor
#121DIMERIC IAP INHIBITORS
#122DIAMINE DERIVATIVES
#123Selective Caspase Inhibitors
#124New 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions
#125New 2-Azetidinone Derivatives Useful In The Treatment Of Hyperlipidaemic Conditions
#126HCV protease inhibitors and uses thereof
#127Gem difluorinated C-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosugery
#128MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS
#129Quinoxaline-containing compounds as hepatitis C virus inhibitors
#130Macrocyclic compounds as antiviral agents
#131HCV protease inhibitors and uses thereof
#132Hepatitis C virus inhibitors
#133Hepatitis C virus inhibitors
#134DIAMINE DERIVATIVES
#135MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS
#136Macrocyclic compounds as antiviral agents
#137Boronic ester and acid compounds, synthesis and uses
#138Intermediates for macrocyclic compounds
#139Fluorinated macrocyclic compounds as hepatitis C virus inhibitors
#140Method of preparing peptide
#141Pharmaceutical salts of macrocyclic modulators of the ghrelin receptor
#142HCV protease inhibitors and uses thereof
#143Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors
#144Methods of using macrocyclic modulators of the ghrelin receptor
#145METHOD FOR PREPARING LYSOBACTIN DERIVATIVES
#146Processes for intermediates for macrocyclic compounds
#147Spatially-defined macrocyclic compounds useful for drug discovery
#148HCV NS3 protease inhibitors
#149Biologically active peptides and compositions, their use
#150Anti-cancer compounds
#151Organic compounds
#152Process for Production of (1,3-Disubstituted Indolyl)-Urea Derivatives, Intermediates Therefor, and Process for Production of the Intermediates
#153PAR-2 antagonists
#154Cyclic Isodityrosine Derivatives
#155Novel Molecular Probes
#156Antiviral Compounds
#157Intermediates for LHRH antagonist synthesis, process for the production, and process for LHRH antagonist production
#158Peptidic compounds
#159Conformationally constrained Smac mimetics and the uses thereof
#160Ring-closing metathesis process for the preparation of macrocyclic peptides
#161Biologically active peptides and their new uses
#162Compounds for enzyme inhibition
#163Process for preparing macrocyclic compounds
#164Compositions comprising carbacephem beta-lactam antibiotics and beta-lactamase inhibitors
#165Macrocyclic Sh2 Domain Binding Inhibitors
#166Boronic ester and acid compounds, synthesis and uses
#167Hepatitis C virus inhibitors
#168Compounds for enzyme inhibition
#169Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#170DIAMINE DERIVATIVES
#171Inhibitors of IAP
#172Boronic ester and acid compounds, synthesis and uses
#173Compounds and compositions as channel activating protease inhibitors
#174Depeptidized inhibitors of hepatitis C virus NS3 protease
#175Collections of Traceable Compounds and Uses Thereof
#176Hepatitis C inhibitor compounds
#177Peptides as NS3-serine protease inhibitors of hepatitis C virus
#178Phenylanine derivatives
#179Compounds for enzyme inhibition
#180Inhibitors of serine proteases
#181Ptb1b photoprobes
#182Pyrrolidine melanocortin-specific compounds
#183Inhibitors of hepatitis C virus NS3 protease
#184Compounds as inhibitors of hepatitis C virus NS3 serine protease
#185Hepatitis C virus inhibitors
#186Substituted propane phosphinic acid derivatives
#187Inhibition of cell motility, angiogenesis, and metastasis
#188Peptides as NS3-serine protease inhibitors of hepatitis C virus
#189HCV NS3 protease inhibitors
#190Methods of using macrocyclic modulators of the ghrelin receptor
#191Administration of HCV protease inhibitors in combination with food to improve bioavailability
#192Hepatitis C inhibitor peptide analogs
#193Potent and specific immunoproteasome inhibitors
#194Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
#195Anti-cancer compounds
#196Hepatitis C virus inhibitors
#197Pyrrolidine derivatives for use in treating heaptitis c virus infection
#198Ultra-high specificity fluorescent labeling
#199Reagents and procedures for multi-label high-specificity labeling
#200Melanocortin receptor ligands
#201Boronic ester and acid compounds, synthesis and uses
#202Antiviral compounds
#203Melanocortin receptor ligands
#204Smart pro-drugs of serine protease inhibitors
#205Compounds for enzyme inhibition
#206Macrocyclic modulators of the ghrelin receptor
#207Hybrid molecules QA, wherein Q is an aminoquinoline and a is an antibiotic or a resistance enzyme inhibitor, their synthesis and their uses as antibacterial agent
#208Granzyme b inhibitors
#209Inhibitors of IAP
#210Method of making metallopeptides
#211Formulation of boronic acid compounds
#212Inhibitors of hepatitis C virus NS3 protease
#213Hepatitis C virus inhibitors
#214Diamine derivatives
#215Compounds as inhibitors of hepatitis C virus NS3 serine protease
#216Compounds for enzyme inhibition
#217Immunopotentiators
#218Metal-binding compounds and uses therefor
#219Process of removing transition metals
#220Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
#221Compositions and methods for inhibiting abnormal cell growth
#222Process for preparing macrocyclic compounds
#223Method of preparing peptide
#224Macrocyclic peptides active against the hepatitis C virus
#225Biologically active peptides and compositions, their use
#226Components for producing amphoteric liposomes
#227Depeptidized inhibitors of hepatitis C virus NS3 protease
#228Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists
#229Compounds which can block the response to chemical substances or thermal stimuli or mediators of inflammation of nociceptors, production method thereof and compositions containing same
#230Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production
#231Peptide compositions for treatment of sexual dysfunction
#232Diamine derivatives
#233Method of removing transition metals
#234Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
#235Macrocyclic peptides active against the hepatitis C virus
#236Macrocyclic antagonists of the motilin receptor
#237Diamine derivatives
#238Hepatitis C inhibitor compounds
#239Carbacephem β-lactam antibiotics
#240Collagen mimics
#241Peptidomimetic inhibitors of STAT activity and uses thereof